February 15, 2007

CONTACT: Kate Olderman
(215) 349-8369
kate.olderman@uphs.upenn.edu

ON-SITE: Karen Kreeger
(215) 349-5658
karen.kreeger@uphs.upenn.edu


PENN Addiction Researcher Presents Talk on Promising Approaches in the
Treatment of Drug Addiction at AAAS Annual Meeting

Live Webcast of Symposium and News Briefing Scheduled

(PHILADELPHIA) – Charles P. O’Brien, MD, PhD, Vice Chair, Department of Psychiatry, University of Pennsylvania Health System, and Research Director, MIRECC, Philadelphia VA Medical Center, will present “Promising Approaches in the Treatment of Drug Addiction” at the 2007 American Association for the Advancement of Science (AAAS) Annual Meeting in San Francisco.  As a part of the Friday, February 16th session, “Addiction and the Brain: Are We Hard-Wired to Abuse Drugs?,” O’Brien will discuss the practical applications of neuroscience research that have led to the development of novel medication approaches and other new medications in the pipeline.

“Neuroscience research unexpectedly led to the discovery of the endogenous opioid system, and subsequently a new treatment for alcoholism and a potential method to stop the revolving door for heroin addicts who relapse shortly after release from prison,” says O’Brien.

O’Brien will also participate in a news briefing featuring brief presentations followed by a Q&A session.

Schedule of events:

News Briefing
Thursday, February 15, 2007
1 – 2 p.m. Pacific Time
AAAS Briefing Room, Nikko Ballroom III
3rd Floor Hotel Nikko, San Francisco, CA

Symposium
Addiction and the Brain: Are We Hard-Wired to Abuse Drugs?
Friday, February 16, 2007
8:30 – 11: 30 a.m. Pacific Time
Hilton San Francisco
Ballroom Level
Continental Ballroom 6

THE SYMPOSIUM WILL BE WEBCAST LIVE AT:

http://www.bnl.gov/bnlweb/pubaf/pr/addictionSymposium.asp

The addiction symposium is organized by the U.S. Department of Energy’s Brookhaven National Laboratory.

###

PENN Medicine is a $2.9 billion enterprise dedicated to the related missions of medical education, biomedical research, and high-quality patient care. PENN Medicine consists of the University of Pennsylvania School of Medicine (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System.

Penn's School of Medicine is ranked #2 in the nation for receipt of NIH research funds; and ranked #3 in the nation in U.S. News & World Report's most recent ranking of top research-oriented medical schools. Supporting 1,400 fulltime faculty and 700 students, the School of Medicine is recognized worldwide for its superior education and training of the next generation of physician-scientists and leaders of academic medicine.

The University of Pennsylvania Health System includes three hospitals, all of which have received numerous national patient-care honors [Hospital of the University of Pennsylvania; Pennsylvania Hospital, the nation's first hospital; and Penn Presbyterian Medical Center]; a faculty practice plan; a primary-care provider network; two multispecialty satellite facilities; and home care and hospice.


This release is available online at
http://www.uphs.upenn.edu/news/News_Releases/feb07/addiction-symposium.html